Javad Seyedzadeh

Javad is a Business Advisor, Corporate Officer, and Senior Executive with an impressive 35-year track record in healthcare leadership. Specializing in imaging, in vitro, and in vivo industries, he has demonstrated unparalleled expertise in Quality Assurance, Regulatory Affairs, and overall operations on a global scale, including North America, Europe, Latin America, and Asia.

His strong business acumen and strategic leadership have been pivotal in navigating organizations through complex business environments worldwide. Javad has worked with companies of all sizes—from startups to Fortune 500s—managing diverse teams and cultures with finesse.

In his role as Senior Vice President of Global Quality Assurance and Regulatory Affairs at Gambro, he not only enhanced quality systems but also played a key role in business strategy, contributing to the company’s successful acquisition by Baxter. His extensive experience also includes tenures at Toshiba Medical Systems, Bayer Healthcare, Siemens Healthcare, and NovaSignal, where he was the Chief of Quality Assurance and Regulatory Affairs.

Javad’s business-oriented approach extends to product development and operational excellence. He has been instrumental in streamlining processes, reducing product costs, and implementing efficient organizational designs. His leadership has been crucial in driving product development strategies that align with regulatory compliance and market needs.

Andy Schultz

Andy Schultz is the Chief Commercial Officer of Neurolutions, Inc. Prior to joining Neurolutions, he was SVP of Revenue and Operations at Candid, a disruptor in the orthodontic clear aligner space. Andy spent nearly 5 years at Candid leading and scaling through periods of high growth and a major DTC to B2B business pivot.

Prior to Candid, Andy held the title of Vice President Customer Experience and Planning at Scotts Miracle-Gro. Over 13 years there he held various leadership roles in sales, operations, strategy and supply chain. Prior to that time, Andy was a First Officer for Northwest Airlink. He served 8 years in the US Navy aboard the USS Enterprise and as a part of the Blue Angels Flight Demonstration Squadron. Andy graduated from Embry-Riddle Aeronautical University.

Lisa Garrett

Lisa Garrett joined Neurolutions in March 2023 and brings over 20 years experience in medical technology companies. Most recently Lisa was the CFO at Cardiva Medical until its acquisition by Haemonetics in 2021. Previously she served as CFO at ForSight Vision5, Inc., a pharmaceutical research company subsequently acquired by Allergan. Prior to ForSight Vision5, Lisa was the CFO at Corventis, Inc., a wearable arrhythmia sensor company acquired by Medtronic in 2014.

Lisa also served in various financial roles at Guidant Corporation, Sybase and Eli Lilly. Lisa currently sits on the board of Channel Medsystems, a medical device company focused on women’s health. Lisa earned a B.B.S. in Accounting and an M.B.A from Indiana University.

Fred Khosravi

Fred Khosravi is a Silicon Valley medical device entrepreneur with over 30 years of experience in medical technology, including management and executive positions in both large and small enterprises. He has co-founded Incept LLC and serves as its managing director, focusing on technology innovation and entrepreneurship in the life-sciences field and occasionally extending to information technology.

Fred is credited as an inventor or co-inventor on over 200 patents and patent applications globally, holds degrees in mechanical engineering from Tennessee Tech University, and is involved in various organizations such as the Center for Strategic and International Studies, Spirit of America, and Technology for America.

William Tai

William Tai is a successful entrepreneur and investor with over 30 years of experience in the technology industry. He is the Founder and Managing Partner of Amed Ventures, a San Francisco Bay Area-based venture capital fund focused on Medical Device and Medical Technologies investments.

He is also the former VP of Business Development at CTBC Bank Corp. William has earned a Bachelor’s Degree in Finance from National Chengchi University and an MBA from Baruch College.

Stavros Vizirgianakis

Stavros G. Vizirgianakis was the former Chief Executive Officer of Misonix (MSON) from 2016- 2021. He has a distinguished career in the medical devices field having worked for United States Surgical Corporation as director of sales for sub-Saharan Africa and later Tyco Healthcare in the capacity of General Manager South Africa.

In 2006, Vizirgianakis co-founded Surgical Innovations, one of the largest privately owned medical device distributors in the African region which later became part of the Ascendis Health group. He also served on the boards of Tenaxis Medical and Bioventus. Current board positions include Tally Surgical and Theragenics.

He is a strategic investor and advisor to numerous startups and established companies in the medical device field. Vizirgianakis has a Degree in Commerce from the University of South Africa.

Calvin Portley

Calvin Portley has extensive work experience in various roles and industries with much of his time spent in healthcare technology commercialization. Calvin is the Chief Business Officer at Neurolutions, a position he has held since May 2020. Prior to that, he worked as a Venture Partner at Dangerous Ventures and the Managing Partner at Avon Growth Management, a lower middle market acquisition firm. Before that, he worked in various marketing and sales leadership positions at Doctor On Demand, Beckman Coulter, Johnson & Johnson, Alcon (a Novartis company), and The Kraft Heinz Company.

Calvin Portley completed his Master of Business Administration (M.B.A.) degree from the UCLA Anderson School of Management in 2014 and obtained his Bachelor of Business Administration (B.B.A) in Marketing from The University of Texas at Arlington in 2003.

Sean Kinsman

Sean has extensive professional experience ranging from acute clinical practice to healthcare entrepreneurship. Data analysis and commercial viability drive his work, helping demystify intricacies to enhance both healthcare delivery and business operations. His personal mission is to revolutionize healthcare by integrating cutting-edge technology with human-centric care, ensuring accessibility, efficiency, and excellence. His journey has been characterized by a relentless pursuit of innovation and efficiency. He seeks opportunities to serve as an innovation catalyst, working with forward-thinking organizations and individuals to develop solutions that truly make a difference. Through perseverance, creativity, and a priority-driven focus on value, he aspires to lead the next wave of breakthroughs that fundamentally reshape how health is defined, delivered, and experienced.

Nancey Trevanian Tsai, MD

Nancey Trevanian Tsai, MD is a board certified Sports Medicine Physician, Diplomate of the American Board of Physical Medicine and Rehabilitation. She is a Clinical Professor of Neurosurgery at the Medical University of South Carolina. She is also the Clinician representative for the IEEE Engineering in Medicine and Biology AdCom, an officer of the South Carolina section of the IEEE, as well as a past Chair of the American Council on Exercise, a past Chair of the South Carolina Medical Association Young Physicians Section, a member of the Medical Society of South Carolina. She has a patent for the Blink Reflexometer in Australia and Japan, and the United States. She has also been a member of the USA Field Archery Team in 2010, 2012, and a national coach for USA Archery/Para- archery, whose athletes include national and world champions.

Kirsten Carroll

Kirsten joined Imperative Care in October 2017 as Vice President Strategic Development, and in early 2020 founded the company’s Patient-at-Home initiative, the development program that served as the basis for the creation of Kandu. Previously, she spent a combined nearly 15 years in the Neurovascular Division of Stryker and Boston Scientific, where she held strategic development, planning, marketing, and product management positions. Kirsten holds several patents in the fields of stroke treatment and detection, and she is the author of several peer-reviewed papers in the field of stroke and access to care.